Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-C in Adult Subjects With Symptomatic Early Hip Osteoarthritis
NCT05276011Phase 2Not yet recruiting
- Sponsor
- Kolon TissueGene, Inc.
- Start
- Oct 2027
- Primary completion
- Oct 2028
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
01
Overview
A Phase 2 trial of Invossa in osteoarthritis (OA), sponsored by Kolon TissueGene, Inc.. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
Invossa
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05276011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276011.